RBx11160 Phase II Dose Ranging Study RBx/MMV05-06

Clinical trial NCT00362050 · COMPLETED

Trial details

NCT number: NCT00362050
Sponsor: Medicines for Malaria Venture
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Plasmodium Falciparum Malaria

Start date: 2006-06-01
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.